Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NicoDerm CQ

This article was originally published in The Tan Sheet

Executive Summary

SmithKline Beecham's nicotine replacement patch is top-selling new product in food, drug and mass merchandise outlets in 1997, Chicago-based Information Resources, Inc. reports in its "New Product Pacesetters" 1998 report. The leading OTC patch recorded sales of $243 mil. in 1997, the report states. In a February teleconference with securities analysts, SmithKline said the brand's U.S. sales were $214 mil. ("The Tan Sheet" Feb. 23, p. 18). According to IRI, sales in the anti-smoking product category increased 75% to $563 mil. in 1997. The IRI study included 767 different product types...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel